Literature DB >> 12467865

Quantitative MR renography using a calibrated internal signal (ERETIC).

F Franconi1, C Chapon, L Lemaire, V Lehmann, L Barantin, S Akoka.   

Abstract

To measure MR renograms, cortical and medullary kidney signal intensity evolution is followed after contrast agent injection. To obtain an accurate quantitative signal measurement, the use of a reference signal is necessary to correct the potential MRI system variations in time. The ERETIC method (Electronic Reference To access In vivo Concentrations) provides an electronic reference signal. It is synthesized as an amplitude modulated RF pulse applied during the acquisition. The ERETIC method was as precise as the external tube reference method but presents major advantages like its free adjustability (shape, location and magnitude) to the characteristics of the organ studied as well as its not taking room inside the magnet. Even though ERETIC showed a very good intrinsic stability, systems' variations still affect its signal in the same way as real NMR signals are affected. This method can be easily implemented on any imaging system with two RF channels.

Mesh:

Year:  2002        PMID: 12467865     DOI: 10.1016/s0730-725x(02)00593-3

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  3 in total

1.  ViP MRI: virtual phantom magnetic resonance imaging.

Authors:  Hervé Saint-Jalmes; Pierre-Antoine Eliat; Johanne Bezy-Wendling; Alejandro Bordelois; Giulio Gambarota
Journal:  MAGMA       Date:  2013-12-15       Impact factor: 2.310

2.  Synthetic signal injection using a single radiofrequency channel.

Authors:  Kenneth I Marro; Donghoon Lee; Eric G Shankland; Clinton M Mathis; Cecil E Hayes
Journal:  J Magn Reson Imaging       Date:  2011-10-05       Impact factor: 4.813

3.  Quantitative in vivo magnetic resonance spectroscopy using synthetic signal injection.

Authors:  Kenneth I Marro; Donghoon Lee; Eric G Shankland; C Mark Mathis; Cecil E Hayes; Seth D Friedman; Martin J Kushmerick
Journal:  PLoS One       Date:  2010-12-28       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.